CUSIP: 07160F107
Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
12,703,483
-
Share change
-
+5,137,758
-
Total reported value
-
$2,782,000
-
Price per share
-
$0.22
-
Number of holders
-
24
-
Value change
-
+$1,019,691
-
Number of buys
-
13
-
Number of sells
-
12
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2022
-
Previous quarter:
Q3 2021
Recent filing periods for CUSIP 07160F107:
Institutional Holders of BAUDAX BIO INC - COM (BXRX) as of Q4 2021
As of 31 Dec 2021,
BAUDAX BIO INC - COM (BXRX) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,703,483 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, BlackRock Inc., GSA CAPITAL PARTNERS LLP, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Amplius Wealth Advisors, LLC, UBS Group AG, Virtu Financial LLC, and NORTHERN TRUST CORP.
This page lists
24
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.